DE3369640D1 - Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain - Google Patents

Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain

Info

Publication number
DE3369640D1
DE3369640D1 DE8383109401T DE3369640T DE3369640D1 DE 3369640 D1 DE3369640 D1 DE 3369640D1 DE 8383109401 T DE8383109401 T DE 8383109401T DE 3369640 T DE3369640 T DE 3369640T DE 3369640 D1 DE3369640 D1 DE 3369640D1
Authority
DE
Germany
Prior art keywords
brain
improvement
treatment
pharmaceutical composition
composition useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383109401T
Other languages
German (de)
English (en)
Inventor
Shizuo Kuriyama
Mikio Saitoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Mitsubishi Chemical Industries Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3369640D1 publication Critical patent/DE3369640D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8383109401T 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain Expired DE3369640D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (1)

Publication Number Publication Date
DE3369640D1 true DE3369640D1 (en) 1987-03-12

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383109401T Expired DE3369640D1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain

Country Status (5)

Country Link
US (2) US4507322A (https=)
EP (1) EP0103897B1 (https=)
JP (1) JPS5955829A (https=)
DE (1) DE3369640D1 (https=)
IT (1) IT1169837B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 ２−（４−メチルアミノブトキシ）ジフェニルメタン・塩酸塩の製造方法
US5869536A (en) 1994-07-12 1999-02-09 Mitsubishi Chemical Corporation Treatment of hyperkinetic disorders
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE430156B (sv) * 1975-06-19 1983-10-24 Mitsubishi Chem Ind Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
JPS606349B2 (ja) * 1975-09-10 1985-02-18 三菱化成工業株式会社 ２―（ω‐アミノアルコキシ）ジフエニルメタン類

Also Published As

Publication number Publication date
JPH0233689B2 (https=) 1990-07-30
IT1169837B (it) 1987-06-03
IT8322949A0 (it) 1983-09-21
EP0103897A1 (en) 1984-03-28
US4507322A (en) 1985-03-26
EP0103897B1 (en) 1987-02-04
JPS5955829A (ja) 1984-03-31
US4576966A (en) 1986-03-18

Similar Documents

Publication Publication Date Title
GB2096468B (en) Improvement in or relating to an apparatus for medical treatment
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
GB8817585D0 (en) Improvements in/relating to apparatus for use in treatment of spinal disorders
GR3002659T3 (en) Pharmaceutical composition for treating inflammation in the eye
GB9014817D0 (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
HUT46538A (en) Process for producing pharmaceutical composition for inhibiting reduction of mental functions
PT76247B (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
DE3369640D1 (en) Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
GB2045612B (en) Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
PT73286A (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
PH16250A (en) Pharmaceutical composition of therapeutic value in the treatment of some shock conditions
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
DE3369296D1 (en) Device for the examination and post treatment of articles
JPS53130440A (en) Novel pharmaceutical composition having obuect to treat especially functional disorder of brain
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
EP0078533A3 (en) Medicinal composition for treating skin disorders
HUT44073A (en) Process for producing purified human angiogene factor and pharmaceutical compositions containing them
GB2173401B (en) Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EISAI CO., LTD. MITSUBISHI KASEI CORP., TOKIO/TOKY

8339 Ceased/non-payment of the annual fee